SCHEMBL255098

SCHEMBL255098

CCCC1CCN(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13479302 1.00
SCHEMBL23251417 1.00
Hydrochloric Acid SCHEMBL30212997 0.98 NCF1 (0.44)
Fluoride SCHEMBL30212665 0.98 NCF1 (0.44)
Cyanide SCHEMBL30330890 0.93 NCF1 (0.41)
Acetic Acid SCHEMBL28757000 0.88 GNAI3 (0.43)
SCHEMBL123480 0.87 NCF1 (0.54)
SCHEMBL29252808 0.86 GNAI3 (0.39)
SCHEMBL4293041 0.86 DRD1 (0.39)
SCHEMBL24477569 0.86 DRD1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119965221-A Lithium ion secondary battery, positive electrode active material, and electric device 宁德时代新能源科技股份有限公司 2025-05-09 CN claimed
CN-119092645-B Lithium ion secondary battery, positive electrode active material, and electric device 宁德时代新能源科技股份有限公司 2025-03-21 CN claimed
CN-119092645-A Lithium ion secondary battery, positive electrode active material, and electric device 宁德时代新能源科技股份有限公司 2024-12-06 CN claimed
CN-119965221-A Lithium ion secondary battery, positive electrode active material, and electric device 宁德时代新能源科技股份有限公司 2025-05-09 CN disclosed
CN-119092645-B Lithium ion secondary battery, positive electrode active material, and electric device 宁德时代新能源科技股份有限公司 2025-03-21 CN disclosed
CN-119092645-A Lithium ion secondary battery, positive electrode active material, and electric device 宁德时代新能源科技股份有限公司 2024-12-06 CN disclosed
CN-114950297-B Device and process for producing hydrofluoroether 浙江诺亚氟化工有限公司 2024-02-23 CN disclosed
US-20230340435-A1 BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE VERVE THERAPEUTICS, INC. 2023-10-26 US disclosed
US-20230340435-A1 BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE VERVE THERAPEUTICS, INC. 2023-10-26 US disclosed
US-11691989-B2 Macrocyclic indoles as Mcl-1 inhibitors ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) 2023-07-04 US disclosed
CN-114814012-B Determination method of lincolamine antibiotics in feed 浙江大学 2023-06-23 CN disclosed
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
US-20100028299-A1 Methods and compositions of treating a flaviviridae family viral infection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2010-02-04 US disclosed
EP-2084765-A2 SECONDARY ELECTROCHEMICAL CELL WITH HIGH RATE CAPABILITY Valence Technology, INC. (US) 2009-08-05 EP disclosed
US-20090156512-A1 potent activity against resistant pneumococci MEIJI SEIKA KAISHA, LTD. (JP) 2009-06-18 US disclosed
US-20080261113-A1 SECONDARY ELECTROCHEMICAL CELL WITH HIGH RATE CAPABILITY VALENCE TECHNOLOGY, INC. 2008-10-23 US disclosed
WO-2008061174-A9 SECONDARY ELECTROCHEMICAL CELL WITH HIGH RATE CAPABILITY VALENCE TECHNOLOGY INC (US) 2008-10-02 WO disclosed
WO-2008061174-A2 SECONDARY ELECTROCHEMICAL CELL WITH HIGH RATE CAPABILITY VALENCE TECHNOLOGY, INC. (US) 2008-05-22 WO disclosed
WO-2008032858-A2 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-20 WO disclosed
US-20070021391-A1 Preventive/remedy for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-25 US disclosed